Cholangiocarcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC
Condition:   Combined Hepatocellular Cholangiocarcinoma Intervention:   Drug: gemcitabine ,oxaliplatin,anlotinib,Sintilimab Sponsor:   Sichuan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials